In the tumor tissues of NEPC patients, AR signaling is low or lost, and such typical NE markers as neuronal-specific enolase 2 (ENO2), synaptophysin (SYP), NCAM1 and chromogranin A(CHGA) are remarkably elevated [23]. This evidence concerns the gene NCAM1 and neoplasm.